Bausch Health Companies (BHC) Gross Margin (2009 - 2026)

Bausch Health Companies has disclosed Gross Margin across 18 years of filings, most recently posting 98.14% for Q1 2026.

• Gross Margin for Q1 2026 came in at 98.14%, up 265.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 94.74% (down 191.0% YoY), and the FY2025 annual result was 100.0%, up 466.0% from the prior year.
• Gross Margin came in at 98.14% for Q1 2026 at Bausch Health Companies, down from 100.14% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 176.11% in Q4 2022 to a low of 70.58% in Q1 2023.
• The 5-year median for Gross Margin is 98.01% (2023), against an average of 95.67%.
• Across the five-year window, Gross Margin soared 7635 bps in 2022 and tumbled 7810 bps in 2023, its largest moves.
• Bausch Health Companies' Gross Margin stood at 176.11% in 2022, then sank by 44 bps to 98.01% in 2023, then fell by 2 bps to 95.66% in 2024, then increased by 5 bps to 100.14% in 2025, then slipped by 2 bps to 98.14% in 2026.
• The last three Gross Margin figures came in at 98.14% (Q1 2026), 100.14% (Q4 2025), and 81.01% (Q3 2025), per Business Quant data.